Gossamer Bio, Inc. (GOSS)

NMS – Real vaqt narxi. Valyuta: USD

0.17

-0.01 (-4.02%)

Yopilishda: Aug 12, 2026, 3:59 PM EDT

0.18

-0.00 (-0.45%)

Bozordan keyin: Aug 12, 2026, 5:14 PM EDT

10.08.2026

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Gossamer Bio, Inc. (NASDAQ: GOSS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Gossamer Bio misrepresented or failed to disclose material information regarding its Phase 3 PROSERA study evaluating seralutinib for the treatment of pulmonary arterial hypertension (PAH).

Videolar

No Data

There is no data to display

Press-relizlar

10.08.2026

Gossamer Bio, Inc. (GOSS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Gossamer Bio, Inc. (GOSS)

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Videolar

No Data

Press-relizlar

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Videolar

No Data

Press-relizlar

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Search stocks

Gossamer Bio, Inc. (GOSS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Gossamer Bio, Inc. (GOSS)

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Videolar

No Data

Press-relizlar

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

Videolar

No Data

Press-relizlar

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm